Evidence map›Paper›PMID 42042516›Full record

ReviewJournal of imaging2026

Cracking the Code: Computational Image Analysis Tools for Histopathological and Morphometric Insights.

Ana Luisa Teixeira de Almeida, Ana Beatriz Gram Dos Santos, Debora Ferreira Barreto-Vieira

Abstract readReview
In one paragraph

Review in Journal of imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ana Luisa Teixeira de AlmeidaLaboratory of Viral Morphology and Morphogenesis, Oswaldo Cruz Institute, Oswaldo Cruz Foundation Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0002-2189-7115
Ana Beatriz Gram Dos SantosLaboratory of Viral Morphology and Morphogenesis, Oswaldo Cruz Institute, Oswaldo Cruz Foundation Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.
Debora Ferreira Barreto-VieiraLaboratory of Viral Morphology and Morphogenesis, Oswaldo Cruz Institute, Oswaldo Cruz Foundation Fiocruz, Rio de Janeiro 21040-900, RJ, Brazil.ORCID 0000-0003-1014-0755

Funding

CNPq 441922/2024-4FAPERJ E-26/201.426/2022FAPERJ E-27/2021/269465FIOTEC IOC-023-FIO-18-2-58
6 · The paper itself

Abstract

The assessment of histopathological features has evolved considerably, transitioning from traditional manual measurements to more sophisticated, technology-assisted approaches. Classical histological evaluation, while foundational and highly reliable, is inherently labor-intensive and subject to inter-observer variability. With the advent of digital pathology, these practices have been progressively enhanced by image processing software, which offers capabilities such as segmentation, feature extraction, and data visualization. However, despite their promise, the integration of machine learning into this branch of pathology faces notable challenges, such as the need for large, high-quality annotated datasets and the integration into existing workflows, which remain significant hurdles. Looking forward, the role of specialists in histological evaluation remains crucial in this evolving landscape. While automation streamlines routine tasks, the expertise of pathologists is indispensable in validating results and interpreting findings in scientific contexts. This comprehensive review explores the trajectory of histological evaluation methods, from manual and classical strategies to cutting-edge digital tools, highlighting the benefits, limitations, and implications of each approach in contemporary practice.

Indexed as

computational histopathologyimage analysis softwaremorphometry

Identifiers

PMID42042516
PMCPMC13118002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.